NEEDLE, HYPODERMIC

The contract, awarded to SZY HOLDINGS, LLC under solicitation SPE2DS-26-T-097X and dated July 8, 2026, is for the procurement of one package of hypodermic needles, NSN 6515010032368, with a total value of $95.66. The item is a medical supply with a 60-month shelf life, requiring no more than nine months to have elapsed from manufacture to delivery, and must be packaged and labeled in full compliance with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards per ASTM D3951 and DLA’s RP001 for palletization, with sealed unit containers ensuring protection against damage and environmental degradation, and mercury-free construction is mandated. All containers must bear lot numbers, MFD-prefixed manufacture dates, unit of issue, and quantity per unit pack, with traceability ensured through 2D Data Matrix barcoding. Delivery is required FOB destination to the Naval Medical Readiness Logistics Command in Williamsburg, Virginia, with an as-directed delivery window of five days, and no fixed start date applies. The contract is administered under a suite of standard Federal Acquisition Regulation and Defense Federal Acquisition Regulation Supplement clauses covering cybersecurity, whistleblower rights, contractor reporting obligations, and supply chain integrity, including mandatory safeguarding of covered defense information and cyber incident reporting under 252.204-7012, prohibition on certain telecommunications equipment under 252.204-7018, and notification of safety issues under 252.246-7003. Deviations under 2026-00038 apply to several small business representation and contract type clauses, indicating agency-specific modifications to standard FAR provisions. Invoicing must be submitted exclusively through Wide Area WorkFlow, with payments governed by the DD Form 1155 and DoDAAC codes listed in the award documentation. The offeror’s small business status and representation of socioeconomic categories, such as 8(a), HUBZone, WOSB, or SDVOSB, were required for eligibility, but no affirmative responses or company-specific data are documented in the solicitation materials. There is no explicit basis of award stated, though pricing is the apparent determining factor given the minimal scope and value. No options, modifications,